mobile
CII's 10th Pharma Summit 2012
HighLights
 

a)      With the huge success of its earlier editions, Confederation of Indian Industry (CII) organized the 10th Pharma Summit 2012, ‘India Pharma Inc: Gearing up for the Next Level of Growth’ Indian pharma industry is on the brink of acquiring global stature by the year 2020. 10th Pharma Summit 2012 delved with the strategies and components the pharma industry can foster for the industry to prosper a notch higher. 

 

b)      Welcoming everyone to the summit Dr. Rajiv Modi, Chairman CII Pharma Summit 2012, Vice Chairman, CII Gujarat State Council and Managing Director Cadila Pharmaceuticals Limited in his inaugural speech said,  “The 10th edition of Pharma Summit aims to explore how the industry can gear up for the next level of growth and serve as a platform to discuss strategies and challenges ahead. The Indian Pharmaceutical Industry is poised for an unprecedented growth. In the coming ten years, it expected to touch a staggering US$ 74 billion in Sales. The Summit focuses on the road map for the future; in order to capitalize on the growing potential of emerging markets to take them to newer heights. India is a land of huge opportunities and with the substantial support of the Government, pharma industry aims to flourish in the coming years. The pharma industry has matured over a period by way of developing efficient processes and cost effective manufacturing pattern. Indian pharma industry is perfectly staged for better future and the ecosystem prevalent is perfectly geared up for new innovations. Pharma industry is our pride and the revenue earner, so we need to cherish it’. 

 

c)      Mr. Maheshwar Sahu, Principal Secretary Industries & Mines Department, Government of Gujarat released a report on CII-PwC ‘India Pharma Inc.: Gearing up for Next Level of Growth’, he also threw light on the future prospect of pharma industry by saying, ‘The future landscape of the pharma industry is prominent because with the rise of the middle class segment and the rise for healthcare to substantial quotient. The pharmaceuticals companies offer quality and affordable healthcare inputs with continuous innovation for better products’. 

 

d)      Setting the tone for the summit, Mr. Sujay Shetty, Executive Director- India Pharma Life Sciences Leader PwC, India said, India is the frontrunner for grabbing the top ten positions in coming years. The industry is in its vibrant state and more innovations and incorporation of latest technology are on their way. We need to compartmentalize our positives for achievement of the global market’. 

 

e)       Dr. Steve Arlington, Global Pharma & Life Sciences Advisory Leader, PwC, UK dealt with the subject of Pharma 20-20, from vision to decision.’ Pharma industry is going through a challenging situation for innovation in growth markets and by 2020 the sales for pharma products are expected to reach 1.5 trillion marks. Chronic diseases like Obesity, Cardio Vascular disease, Hypertension, diabetes are still exerting extreme pressure on healthcare sector for prevention and cure using innovations. The focus should be on producing cost effective medicines and by 2020, the BRIC economics alone will account for 33% of the world’s total GDP. The main motto of the pharma industry should now involve the working of R&D, Health economics and Marketing strategies for better prospect. Conjoined efforts of value for money, lifecycle, regulatory acts, skills & resources, access and transparency can confirm new regulatory environment for the pharmaceutical companies’. 

 

f)        The interactive CEO’s roundtable included discussion on core theme of Opportunities & Challenges for the Indian Pharma Inc. & was infused with industry inputs by leaders like Dr Rajiv Modi, Chairman, CII Pharma  Summit & Vice – Chairman CII Gujarat Council, Mr Pankaj Patel, CMD, Cadila Healthcare Ltd., Dr H G Koshia, Commissioner, FDCA, Government of Gujarat, Mr Venkat Jasti, Charirman & CEO Suven Life Sciences, Mr Smitesh Shah, CMD, Calyx Chemicals & Pharmaceuticals, Mr Amit Bakshi, Founder Managing Director, Eris Lifesciences Pvt. Ltd., Mr Aiyaz Tobaccowalla, Managing Director Pfizer Ltd., Mr Anthony Farino, Partner – Emerging Markets Leader, PwC, US. It was discussed that the Indian Pharma industry has done an incredible job in making innovation in drugs that treat rare diseases. The present environment is innovation friendly and it is a common thought that Genomics drive the growth of the healthcare sector now. Innovation is synonymous with continuous growth module that includes upgrading the existing drugs, marketing low cost medicines.  It was also opined by industry that we should always give boost to the industry that has a future of tremendous growth. Our innovations should be in coordination with process factor, and we need to develop efficient ways for the product development. Innovation is critical and important to advocate the prophecy of growing nature of pharmaceutical industry.

 

g)      In the swift stride of globalization, Gujarat surfaces as the hub of pharmaceutical industry. It was also discussed that the incorporation of latest vaccine technology will ensure better growth in life sciences at an affordable cost.

 
Description

CII WR organized its 10th Pharma Summit on 5 November 2012 at Hotel Courtyard by Marriott, Ahmedabad under the Chairmanship of Dr Rajiv Modi, Vice Chairman - CII Gujarat State Council and Managing Director, Cadila Pharmaceuticals Ltd.  

 

The Summit was supported Bulk Drug Manufacturers Association (BDMA), Confederation of Indian Pharmaceutical Industry (CIPI), Food & Drug Control Administration (FDCA), Indian Chemical Council (ICC), Indian Drug Manufacturers' Association (IDMA), Organisation of Pharmaceutical Producers of India (OPPI) and Pharmaceutical Export Promotion Council (PHARMEXCIL) along with TenderTiger and PricewaterhouseCoopers (PwC) as the Online and Knowledge Partners respectively.

 

The Summit was inaugurated by Mr Maheshwar Sahu, IAS, Principal Secretary-Industries & Mines Department, Government of Gujarat who delivered the Special Address. The galaxy of speakers at the Summit included senior professionals from the Pharmaceutical Industry. 

 

The Pharma Summit 2012 covered a wide range of topics like India Pharma Inc. – Gujarat Advantage & New Vaccine Technology - Road Ahead; India Pharma Inc. – Establishing a New Vaccine Platform in India; India Pharma Inc. – Will Alliances & Partnerships continue to Drive Growth?; India Pharma Inc. – Newer Trends & Innovation Driving the Growth and an exclusive CEOs’ Interactive Roundtable: ‘India Pharma Inc.: Driving Profitable Growth in Indian Market - Opportunities & Challenges’.

 

One of the highlights of the Summit was the release of CII – PWC Report on ‘India Pharma Inc.: Gearing up for the Next Level of Growth’.

Sponsored By
Knowledge Resources
You will get access to following Knowledge Resources by subscribing to the Digital Library of this event.
 
A1 - Dr Rajiv Modi, Chairman-CII Pharma Summit 2012 & Vice Chairman-CII Gujarat State Council and Managing Director, Cadila Pharmaceuticals Ltd delivering welcome and introductory remarks at the inaugural plenary of the 10th edition of Pharma Summit 2012.
A2 - Presentation on “Summit & its Objectives” by Mr Sujay Shetty, Executive Director-India Pharma Life Sciences Leader, PwC, India at the inaugural plenary of the 10th edition of Pharma Summit 2012.
A4 - Release of CII-PwC Report ‘India Pharma Inc.: Gearing up for the Next Level of Growth’ at the inaugural plenary of the 10th edition of Pharma Summit 2012.
A6 - Dr Rajiv Modi, Chairman-CII Pharma Summit 2012 & Vice Chairman-CII Gujarat State Council and Managing Director, Cadila Pharmaceuticals Ltd delivering concluding remarks at the inaugural plenary of the 10th edition of Pharma Summit 2012.
B1 - Session Moderator Mr Vikas Dandekar, India Bureau Chief-Elsevier Business Intelligence, PharmaAsia News delivering opening remarks at the CEOs’ Interactive Roundtable: ‘India Pharma Inc.: Driving Profitable Growth in Indian Market-Opportunities & Challenges’ of the 10th edition of Pharma Summit 2012.
B4 - Dr Rajiv Modi, Chairman-CII Pharma Summit 2012 & Vice Chairman-CII Gujarat State Council and Managing Director, Cadila Pharmaceuticals Ltd delivering concluding remarks at the CEOs’ Interactive Roundtable: ‘India Pharma Inc.: Driving Profitable Growth in Indian Market-Opportunities & Challenges’ of the 10th edition of Pharma Summit 2012.
C1 - Session Chairman Dr Rajiv Modi, Chairman-CII Pharma Summit 2012 & Vice Chairman-CII Gujarat State Council and Managing Director, Cadila Pharmaceuticals Ltd delivering opening remarks at the Plenary I: ‘India Pharma Inc.: Gujarat Advantage & New Vaccine Technology-Road Ahead’ of the 10th edition of Pharma Summit 2012.
C2 - Dr H G Koshia, Commissioner-Food & Drug Control Administration, Government of Gujarat delivering Gujarat Advantage at the Plenary I: ‘India Pharma Inc.: Gujarat Advantage & New Vaccine Technology-Road Ahead’ of the 10th edition of Pharma Summit 2012.
C3 - Dr Gregory Glenn, Senior Vice President & Chief Medical Officer, Novavax Inc, USA delivering Establishing a New Vaccine Technology: To India and Back at the Plenary I: ‘India Pharma Inc.: Gujarat Advantage & New Vaccine Technology-Road Ahead’ of the 10th edition of Pharma Summit 2012.
CEOs Interactive Roundtable on India Pharma Inc.: Driving Profitable Growth in Indian Market-Opportunities & Challenges
D1 - Session Moderator Mr Vikas Dandekar, India Bureau Chief-Elsevier Business Intelligence, PharmaAsia News delivering opening remarks at the Panel Discussion: Plenary II: ‘India Pharma Inc.: Establishing a New Vaccine Platform in India’ of the 10th edition of Pharma Summit 2012.
D2 - Dr Ashok Panwar, Vice President-QA & RA-Biotech, Cadila Pharmaceuticals Ltd addressing at the Panel Discussion: Plenary II: ‘India Pharma Inc.: Establishing a New Vaccine Platform in India’ of the 10th edition of Pharma Summit 2012.
D3 - Dr Jane Halpern, Vice President-Regulatory Affairs, Novavax Inc., USA addressing at the Panel Discussion: Plenary II: ‘India Pharma Inc.: Establishing a New Vaccine Platform in India’ of the 10th edition of Pharma Summit 2012.
D4 - Dr Gregory Glenn, Senior Vice President & Chief Medical Officer, Novavax Inc., USA addressing at the Panel Discussion: Plenary II: ‘India Pharma Inc.: Establishing a New Vaccine Platform in India’ of the 10th edition of Pharma Summit 2012.
D5 - Dr Timothy Hahn, Senior Vice President-Manufacturing & Process Development, Novavax Inc., USA addressing at the Panel Discussion: Plenary II: ‘India Pharma Inc.: Establishing a New Vaccine Platform in India’ of the 10th edition of Pharma Summit 2012.
D6 - Dr H G Koshia, Commissioner-Food & Drug Control Administration, Government of Gujarat addressing at the Panel Discussion: Plenary II: ‘India Pharma Inc.: Establishing a New Vaccine Platform in India’ of the 10th edition of Pharma Summit 2012.
Dr Steve Arlington, Global Pharma & Life Sciences Advisory Leader, PwC, UK addressing the Pharma Summit 2012
E1 - Session Moderator Mr Venkat Jasti, Chairman & Chief Executive Officer, Suven Life Sciences Ltd delivering opening remarks at the Panel Discussion: Plenary III: ‘India Pharma Inc.: Will Alliances & Partnerships continue to Drive Growth?’ of the 10th edition of Pharma Summit 2012.
E2 - Mr Ramesh Swaminathan, President-Finance & Planning, CFO, Lupin Ltd addressing at the Panel Discussion: Plenary III: ‘India Pharma Inc.: Will Alliances & Partnerships continue to Drive Growth?’ of the 10th edition of Pharma Summit 2012.
E3 - Dr Rajiv Desai, President-Corporate Quality, Dishman Pharmaceuticals and Chemicals Ltd addressing at the Panel Discussion: Plenary III: ‘India Pharma Inc.: Will Alliances & Partnerships continue to Drive Growth?’ of the 10th edition of Pharma Summit 2012.
E4 - Mr Ketan Patel, Chairman & Managing Director, Troikaa Pharmaceuticals Ltd addressing at the Panel Discussion: Plenary III: ‘India Pharma Inc.: Will Alliances & Partnerships continue to Drive Growth?’ of the 10th edition of Pharma Summit 2012.
F1 - Session Moderator Mr Ajit Kapadia, Vice Chairman-Centre for Fuel Studies and Research & Chairman-Quanta Process Solutions delivering opening remarks at the Panel Discussion: Plenary IV: ‘India Pharma Inc.: Newer Trends & Innovation Driving the Growth’ of the 10th edition of Pharma Summit 2012.
F2 - Dr Timothy Hahn, Senior Vice President-Manufacturing & Process Development, Novavax Inc., USA addressing at the Panel Discussion: Plenary IV: ‘India Pharma Inc.: Newer Trends & Innovation Driving the Growth’ of the 10th edition of Pharma Summit 2012.
F3 - Mr Pankaj Kumar Gupta, Co-Chairman, CII Gujarat State Task Force on ICT and Automation & Principal Consultant-Government Industry Solutions Unit, Tata Consultancy Services addressing at the Panel Discussion: Plenary IV: ‘India Pharma Inc.: Newer Trends & Innovation Driving the Growth’ of the 10th edition of Pharma Summit 2012.
F4 - Mr Raghavendra Shenoy, Vice President-Ethicon Products, Johnson & Johnson Medical, India addressing at the Panel Discussion: Plenary IV: ‘India Pharma Inc.: Newer Trends & Innovation Driving the Growth’ of the 10th edition of Pharma Summit 2012.
F5 - Mr V Viswanathan addressing at the Panel Discussion: Plenary IV: ‘India Pharma Inc.: Newer Trends & Innovation Driving the Growth’ of the 10th edition of Pharma Summit 2012.
F7 - Dr Rajiv Modi, Chairman-CII Pharma Summit 2012 & Vice Chairman-CII Gujarat State Council and Managing Director, Cadila Pharmaceuticals Ltd delivering summit wrap up at the the Plenary IV: ‘India Pharma Inc.: Newer Trends & Innovation Driving the Growth’ of the 10th edition of Pharma Summit 2012.
India Pharma Inc.: Driving Profitable Growth in Indian Market-Opportunities & Challenges - An Open House Discussion
India Pharma Inc.: Establishing a New Vaccine Platform in India - An Open House Discussion
India Pharma Inc.: Gearing up for the next level of growth
India Pharma Inc.: Gujarat Advantage & New Vaccine Technology-Road Ahead - An Open House Discussion
India Pharma Inc.: Newer Trends & Innovation Driving the Growth - An Open House Discussion
India Pharma Inc.: Will Alliances & Partnerships continue to Drive Growth? - An Open House Discussion
Mr Maheshwar Sahu, IAS, Principal Secretary, Industries & Mines Department, Government of Gujarat addressing the Pharma Summit 2012.
 
Charges to access Event
 
Participant TypeAmount (in Rs)
Member
0
NonMember
0